Jonathan B. Kelley
About Jonathan B. Kelley
Jonathan B. Kelley serves as a Senior Medical Science Liaison at Aimmune Therapeutics and has extensive experience in the medical science field, including previous roles at Eisai and Janssen Pharmaceuticals. He holds a PhD from the University of Miami and has worked in various capacities across multiple organizations since 2002.
Current Role at Aimmune Therapeutics
Jonathan B. Kelley serves as a Senior Medical Science Liaison at Aimmune Therapeutics, a position he has held since 2021. He operates in the Miami-Fort Lauderdale Area, where he contributes to the company's mission in advancing therapeutics for food allergies. His role involves engaging with healthcare professionals and providing scientific information to support the clinical and commercial objectives of Aimmune Therapeutics.
Previous Experience at Eisai
Before joining Aimmune Therapeutics, Kelley worked at Eisai US as a Medical Science Liaison from 2019 to 2021. During his time in the New York City Metropolitan Area, he focused on building relationships with key opinion leaders and delivering scientific insights related to Eisai's portfolio. His experience at Eisai laid the groundwork for his current role in the pharmaceutical industry.
Education and Academic Background
Kelley has an extensive educational background. He studied at Loyola High School of Los Angeles and later attended the University of California, Berkeley, where he earned a Bachelor of Arts degree. He pursued further education at the University of Miami, Miller School of Medicine, achieving a PhD from 2006 to 2010. Additionally, he studied at Harvard Medical School, obtaining a Certificate of Achievement in 2020. He has been studying at the University of Southern California since 2002.
Career Path and Previous Roles
Kelley's career includes various roles in the pharmaceutical and medical communications sectors. He worked as a Clinical Researcher at the Terasaki Institute for Biomedical Innovation from 2005 to 2006 and served as a Research Assistant in Cognitive Neuroscience at the University of California, Berkeley from 2002 to 2005. He also held positions at The Janssen Pharmaceutical Companies of Johnson & Johnson, where he worked as a Postdoctoral Scientist EMEA and later as a Senior Regulatory Medical Writing Scientist. His experience also includes a role as Regional Field Medical Director at Life Molecular Imaging from 2018 to 2019.